Model Context Protocol


Model Context Protocol for 1000 Genomes 30x on GRCh38 dataset, sequenced & aligned by New York Genome Center, is available for LLMs integrations.


Key Features

Remote MCP

Remote MCP service is available online via Streamable HTTP:


Source code

MCP server can be run locally with MCP over stdio transport. Can be started as a subprocess by MCP clients (like Claude Desktop or Goose).

Source code + installation:


Examples

Answers below are from Sonnet 4.5: some from multi-agent Research system, some with extended thinking mode, and some from a single-agent system in normal mode.

Identify potential modifier variants for well-known pathogenic alleles in TTN - variants that consistently co-occur in the same haplotype block with pathogenic alleles and may alter severity or penetrance. Conduct research for pathogenic alleles documented in the literature. Use KGP dataset of healthy individuals to find potential modifier variants. Start with 100kb for "the same haplotype block" definition, then extend if required. Evaluate statistical significance for the best modifier candidates found. No initial constraints for modifier types.”

or

“Which regions in POLR2A are most likely disease-critical, with strong purifying selection, based on available variation patterns across functional domains in KGP ? Do statistical evaluation.”

or

“In what cardiac related genes, e.g. ion channels, variants in KGP dataset near catalytic residues or ligand-binding pockets show strong depletion compared to flanking residues (±20 amino acids) ?”

or

“Are there patterns of variation in KGP dataset that suggest digenic or oligogenic interactions for Bardet-Biedl syndrome ? Check variety of combinations and zygosity patterns.”

or

“Which variants in the HBB gene are unexpectedly tolerated in the KGP dataset with at least several annotation sources in agreement with regard to their expected pathogenicity ?”

or

“Rank all rare KGP variants in genes associated with arrhythmia disorder by their expected clinical relevance, not by predicted pathogenicity alone. Find affected individuals with highest clinical priority variants.”


Terms and Conditions